Finance

Beta
Lists
Equity sectors
Symbols
Symbols
Price
Change
% Change
Trend
Prev Close
Open
High
Low
Volume
Mkt Cap
SIXB
Materials
SIXB
Materials
SIXB
-0.32%
1,100.57
-3.53
-0.32%
1,104.101,103.921,108.751,097.16
SIXC
Communications
SIXC
Communications
SIXC
+0.16%
605.15
+0.99
+0.16%
604.16604.16610.19604.12
SIXE
Energy
SIXE
Energy
SIXE
-0.22%
1,195.19
-2.62
-0.22%
1,197.811,200.581,213.071,192.02
SIXI
Industrials
SIXI
Industrials
SIXI
-0.03%
1,739.91
-0.50
-0.03%
1,740.411,739.551,750.271,730.60
SIXM
Financials
SIXM
Financials
SIXM
+0.65%
638.56
+4.12
+0.65%
634.44633.13639.87633.01
SIXR
Staples
SIXR
Staples
SIXR
-1.11%
831.57
-9.33
-1.11%
840.90839.53841.73831.10
SIXRE
Real estate
SIXRE
Real estate
SIXRE
-0.82%
213.36
-1.77
-0.82%
215.13215.13215.85213.24
SIXT
Technology
SIXT
Technology
SIXT
+0.17%
3,234.18
+5.47
+0.17%
3,228.713,225.623,235.433,198.95
SIXU
Utilities
SIXU
Utilities
SIXU
-0.02%
935.65
-0.22
-0.02%
935.87938.37942.00935.65
SIXV
Health care
SIXV
Health care
SIXV
-0.54%
1,449.26
-7.86
-0.54%
1,457.121,452.741,466.881,449.18
SIXY
Discretionary
SIXY
Discretionary
SIXY
-0.72%
2,382.45
-17.39
-0.72%
2,399.842,389.712,394.612,371.22
ABOS:NASDAQ
Acumen Pharmaceuticals Inc
$2.52
-1.95%
(-0.050) 1D
$2.67
+5.95% (+0.15)
After hours
Closed: Apr 27, 4:00:01 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for ABOS...
Open
$2.57
High
$2.69
Low
$2.50
Mkt. cap
182.01M
Avg. vol.
786.66K
Volume
0.00
52-wk high
$3.60
52-wk low
$0.95
EPS
-$2.00
Beta
0.33
Shares outstanding
72.21M
No. of employees
60
News stories
From sources across the web
About Acumen Pharmaceuticals Inc
CEO-
Employees60
FoundedJan 1, 1996
HeadquartersNewton, Massachusetts, United States
SectorBiotechnology
Last report
Mar 26, 2026
Fiscal Period
Q4 2025
Normalized EPS / Estimate
-0.41/ (-0.56 est.)USD
+26.29%beat
Revenue / Estimate
-/ (0.00 est.)USD
Fiscal Q4 2025 earnings call
Waiting for the earnings call
At a glanceInsights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Revenue
-
-
-
-
Cost of goods sold
25.27M
37.12M
21.97M
20.53M
Cost of revenue
25.27M
37.12M
21.97M
20.53M
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
5.10M
4.62M
4.54M
4.67M
Operating expense
5.10M
4.62M
4.54M
4.67M
Total operating expenses
30.37M
41.75M
26.51M
25.20M
Operating income
-30.37M
-41.75M
-26.51M
-25.20M
Other non operating income
126.00K
-169.00K
-509.00K
-174.00K
EBT including unusual items
-28.80M
-40.95M
-26.45M
-25.14M
EBT excluding unusual items
-28.80M
-40.95M
-26.45M
-25.14M
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-28.80M
-40.95M
-26.45M
-25.14M
Net profit margin
-
-
-
-
Earnings per share
-0.48
-0.68
-0.44
-0.41
Interest and investment income
2.47M
2.02M
1.64M
1.32M
Interest expense
-1.02M
-1.05M
-1.07M
-1.09M
Net interest expenses
1.45M
969.00K
571.00K
235.00K
Depreciation and amortization charges
-
-
-
-
EBITDA
-30.36M
-41.73M
-26.50M
-25.19M
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more

Research

My tasks
You haven't created a task yet
Your tasks will appear here. Schedule tasks and put Google Finance to work while you're away.
Templates
Watchlist briefing
A daily pre-market analysis of your watchlist
Upcoming Earnings
Upcoming earnings reports in the week
Abnormal Volatility & Volume
Volatility and volume early warning today
AI content may include mistakes. Learn more